MingMed is a Chinese cancer therapy and vision care firm.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 9, 2021 | Series A | $50M | 4 | — | — | Detail |
Mar 17, 2021 | Series A | $60M | 3 | Gaorong Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Flower City Ventures | — | Series A |
Jifeng Ventures | — | Series A |
JCP Capital | — | Series A |
Gaorong Capital | — | Series A |
Hengqin Financial Investment | — | Series A |